and The Members of the Committee for the Treatment of Turner syndrome. Clinical trials of GH treatment in patients with Turner’s syndrome- a consideration of final height.
(1996). Delemarre-van de Waal HA. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome.
(1992). Delemarre-van der Waal HA. Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation.
(2000). Disease Control and Prevention and National Center for Health Statistics
Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner’s syndrome.
Final height in girls with Turner’s syndrome after long-term growth hormone treatment in three dosages and low doses estrogens.
Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
For The Turner Syndrome Consensus Study Group. Care of Girls and Women with Turner Syndrome:
Genentech Collaborative Group. Decreased metabolic clearance or endogenous growth hormone and specific alterations in pulsatile mode of growth hormone secretion occur in prepuberal girls with Turner’s syndrome.
(1985). Growth curve for girls with Turner syndrome. Arch Dis Child.
Growth hormone in Turner syndrome: twenty years after, what can we tell our patients?
Growth hormone therapy of Turner syndrome: the impact of the age of estrogen replacement on final height.
Growth hormone therapy of Turner’s syndrome: beneficial effect on adult height.
(1999). Growth-promotion strategies in Turner’s syndrome.
(2001). Height enhancement in Turner syndrome is often not clinically significant. The Endocrinologist.
Kabi International Growth Study. Prediction of long-term response to recombinant human growth hormone in Turner’s syndrome: development and validation of mathematical model.
Late or delayed induced or spontaneous puberty in girls with Turner’s syndrome treated with growth hormone does not affect final height.
Long-term effects of growth hormone on height in Turner syndrome: the results of a 5-year multicentric study in Japan. In: Hibi I, Takano K, eds. Basic and clinical approach to Turner syndrome,
Management of Turner’s Syndrome.
(1998). Near normalization of final height with adapted doses of growth hormone in Turner’s syndrome.
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome.
Pubertal Height Gain in Ullrich-Turner Syndrome.
Recommendations for diagnosis and management of Turner syndrome.
Renewed catch-up growth with increased replacement doses of human growth hormone.
(1997). Short-and long-term (final height) growth responses to growth hormone therapy in patients with Turner syndrome: correlation of Growth response to stimulated GH levels, spontaneous GH secretion, and Karyotype. Horm Res.
(1997). Síndrome de Turner: tratamento da baixa estatura com hormônio de crescimento. Arq Bras Endocrinol Metab.
Standards for children’s height at ages 2-9 years allowing for height of parents.
The Canadian Growth Hormone Advisory Committee. Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial.
(1994). The Dutch Growth Hormone Working Group. Comparative effect of two doses of growth hormone for growth hormone deficiency. Arch Dis Child.
(1992). The Genentech National Cooperative study group. Growth hormone therapy in Turner’s syndrome: an update on final height. Genentech National Cooperative Study Group. Acta Paediatr Suppl.
The short stature homeobox gene SHOX is involved in abnormalities in Turner syndrome. Hum Mol Genet.
Turner syndrome study group. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to nearfinal height.